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Dysfunction of the proximal tubule (PT) is associated with
variable degrees of solute wasting and low-molecular-weight
proteinuria. We measured metabolic consequences and
adaptation mechanisms in a model of inherited PT disorders
using PT cells of ClC-5-deficient (Clcn5Y/) mice, a well-
established model of Dent’s disease. Compared to cells taken
from control mice, those from the mutant mice had increased
expression of markers of proliferation (Ki67, proliferative cell
nuclear antigen (PCNA), and cyclin E) and oxidative
scavengers (superoxide dismutase I and thioredoxin).
Transcriptome and protein analyses showed fourfold
induction of type III carbonic anhydrase in a kidney-specific
manner in the knockout mice located in scattered PT cells.
Kidney-specific carbonic anhydrase type III (CAIII)
upregulation was confirmed in other mice lacking the
multiligand receptor megalin and in a patient with Dent’s
disease due to an inactivating CLCN5 mutation. The type III
enzyme was specifically detected in the urine of mice lacking
ClC-5 or megalin, patients with Dent’s disease, and in PT cell
lines exposed to oxidative stress. Our study shows that lack
of PT ClC-5 in mice and men is associated with CAIII
induction, increased cell proliferation, and oxidative stress.
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The epithelial cells lining the proximal tubule (PT) segment
of the kidney play an essential role in reabsorbing solutes
filtrated by the glomeruli. In particular, PT cells reabsorb
albumin and low-molecular-weight (LMW) proteins through
an active endocytic pathway that involves two multiligand-
binding receptors, megalin and cubilin, which are abundantly
expressed at the brush border.1 Upon ligand binding, the
receptors interact and are internalized into coated vesicles,
with subsequent delivery to endosomes and lysosomes for
ligand processing and receptor recycling. This endocytic
trafficking involves the progressive acidification of the
endosome–lysosome pathway in PT cells, a process driven
by the vacuolar Hþ -ATPase (V-ATPase) complex.2
The generalized dysfunction of the PT, named ‘renal
Fanconi syndrome,’ is associated with variable degrees of
solute wasting and LMW proteinuria, which can lead to
severe clinical manifestations, such as growth retardation,
rickets, nephrocalcinosis, and renal failure. Recent insights
into rare inherited disorders show the importance of
receptor-mediated endocytosis in the pathophysiology of
PT dysfunction. Inactivating mutations in the CLCN5 gene,
which encodes the endosomal Cl/Hþ exchanger ClC-5, are
associated with Dent’s disease, an X-linked renal Fanconi
syndrome associated with hypercalciuria nephrocalcinosis,
nephrolithiasis, and renal failure in some patients.3 ClC-5 is
primarily localized in PT cell endosomes, where it
co-distributes with the V-ATPase.4,5 Genetic inactivation of
Clcn5 in mice causes renal tubular defects that mimic human
Dent’s disease, including severe PT dysfunction with
impaired endocytosis and trafficking defects of megalin and
cubilin leading to LMW proteinuria.6–8 Similarly, the
functional loss of cubilin in Imerslund–Gra¨sbeck disease9 or
the genetic inactivation of megalin (Lrp2) in mice10 lead to
PT dysfunction with LMW proteinuria.
The biochemical and metabolic outcomes of the PT cell
dysfunction associated with inherited renal Fanconi
syndrome and the adaptative mechanisms potentially
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involved remain poorly understood. Recently, Wilmer et al.11
have reported an increased oxidative stress and altered redox
status in PT cells cultured from the urine of patients with
cystinosis, a major cause of inherited renal Fanconi
syndrome, suggesting that PT dysfunction may be associated
with oxidative stress. In this study, we have used Clcn5
knockout (KO) mice as a well-defined model of Dent’s
disease and generalized renal Fanconi syndrome6,7 to
investigate the metabolic consequences and adaptative
mechanisms of PT dysfunction. The Clcn5Y/ kidneys were
characterized by higher cell proliferation and oxidative stress,
and the induction of type III carbonic anhydrase (CAIII)—an
early mesodermal marker with the lowest hydratase activity
of the CA isoforms and no documented role in the kidney.12
CAIII was exclusively distributed in scattered PT cells and was
excreted in Clcn5Y/ urine. These data were confirmed in
patients with Dent’s disease and investigated in other mouse
models of PT dysfunction and PT cell lines exposed to
oxidant conditions. Taken together, these observations
suggest that generalized PT dysfunction due to the loss of
ClC-5 is associated with increased cell proliferation,
dedifferentiation, and oxidative stress. Our in vitro studies
in PT cells support the hypothesis that CAIII production may
play a role in response to oxidative damage.
RESULTS
Proliferation and oxidative stress in Clcn5Y/ kidneys
Real-time reverse transcription-PCR (RT-PCR) analyses
(Figure 1) showed a significant increase in the expression
of proliferative cell nuclear antigen (PCNA), Ki67, cyclin E,
and osteopontin in the kidneys of Clcn5Y/ mice. Distinct
reactive oxygen species scavengers, such as type I superoxide
dismutase and thioredoxin, were also upregulated, suggesting
the solicitation of cell oxidative defenses in Clcn5Y/ kidneys
(Figure 1). These results, obtained in 12–week-old mice, were
also observed in 1-year-old Clcn5Y/ mice (data not shown).
Immunohistochemistry detected a 3.5-fold increase in the
number of PCNA- and Ki67-positive cells in ClC-5-deficient
kidneys (B1.8% of PT cells) vs controls (B0.5% of PT cells)
(Figure 2). Comparative measurement of ethidium fluores-
cence in kidney sections revealed that the lack of ClC-5 was
associated with a major increase in the production of
superoxide O2
K– anion in PT cells (Figure 2). These
observations showed that the generalized PT dysfunction
due to the loss of ClC-5 is reflected by significant cell
proliferation and a major oxidative stress that solicitates
reactive oxygen species scavengers.
Comparison of Clcn5Y/þ and Clcn5Y/ renal transcriptomes
We next used the amplified fragment length polymorphism
(AFLP) procedure to identify genes possibly involved in
adaptative mechanisms against PT dysfunction. Using one-
third of the possible AFLP primer combinations (see
Materials and Methods), a total of 10 cDNA bands were
identified as differentially expressed in 12-week-old Clcn5Y/
vs Clcn5Y/þ kidneys. One of these bands, significantly
upregulated in Clcn5Y/ samples, was identified as a
transcript of Car3 (GenBank accession no. M27796),
encoding CAIII. The other cDNA bands, which were
differentially expressed in Clcn5Y/ kidneys, corresponded
to unidentified mouse contigs. Quantitative real-time
RT-PCR was used to validate these results by comparing
the mRNA expression of CAIII and CAII, the most abundant
CA isoform in the kidney (Figure 3a). The CAIII mRNA
expression was approximately fivefold lower than CAII in
wild-type kidneys. However, the CAIII transcript was
significantly upregulated in ClC-5-deficient kidneys (ratio:
553±48% of Clcn5Y/þ level, n¼ 6), whereas CAII mRNA
expression remained unchanged (94±8% of Clcn5Y/þ level).
A similar induction of CAIII expression was also observed in
1-year-old Clcn5Y/ kidneys, and the results were confirmed
on laser capture microdissected cortex samples (data not
shown). The upregulation of CAIII mRNA associated with
the loss of ClC-5 was specific to the kidney, as CAIII mRNA
expression levels in liver, skeletal muscle (vastus lateralis),
and lung from Clcn5Y/ mice were unchanged (Figure 3b).
These data, obtained using AFLP coupled with real-time
RT-PCR, evidenced a significant and kidney-specific induc-
tion of Car3 mRNA expression in mice lacking ClC-5.
Expression of CAIII in Clcn5 kidney and urine
Affinity-purified anti-CAIII antibodies, with no cross-
reactivity for purified CAI and CAII,13 were used to further
investigate CAIII expression in the kidney. These antibodies
did not detect any specific signal with Car3 KO kidney
samples, whereas anti-CAII antibodies recognized the
appropriate isoform in all samples (Figure 3c). The distinc-
tion between CAII and CAIII isoforms was facilitated by their
different electrophoretic mobility in 14% sodium dodecyl
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Figure 1 | Cell proliferation and oxidative stress in ClC-5-deficient
kidneys: real-time RT-PCR. Real-time RT-PCR quantification of
mRNA expression of proliferative cell nuclear antigen (PCNA), Ki67,
cyclin E, osteopontin, catalase, type I superoxide dismutase (SOD),
and thioredoxin in kidneys from Clcn5Y/ vs Clcn5Y/þ 12-week-old
mice (n¼ 6 pairs). The mRNA levels were adjusted to GAPDH before
quantification and calculated upon the formula: efficiencyDDCt . The
Clcn5Y/ kidneys show an increased expression of both cell
proliferation and oxidative stress markers. Values are presented as
mean ratios±s.d., with Clcn5Y/þ level set at 100%; *Po0.05.
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sulfate-polyacrylamide gel electrophoresis, with CAIII show-
ing a slightly faster migration pattern (B27 kDa) than CAII
(B29 kDa) (Figure 3d). Using these antibodies, we con-
firmed the specific, fourfold upregulation of CAIII in ClC-5-
deficient kidneys, contrasting with the lack of changes in
CAII expression (Figure 3e and f). Similar results were
obtained by using a monoclonal antibody against CAIII (data
not shown).
Immunoblotting analyses detected a specific excretion of
CAIII in urine samples from Clcn5Y/ mice (Figure 4a) and
in the urine of three unrelated patients with Dent’s disease
(Figure 4b). It must be noted that CAIII was detected in
simple, non-centrifuged urine samples and that variable
levels of CAII could also be detected in such samples,
irrespective of the genotype and CAIII levels (data not
shown). Thus, CAIII expression is significantly and specifi-
cally increased in ClC-5-deficient kidneys, and CAIII is
detected in the urine of mice and patients lacking ClC-5.
Cellular and subcellular distribution of CAIII in mouse kidney
In normal kidney, a weak immunoreactive signal for CAIII
was observed in a subset of PT cells located in the outer
cortex, identified by their apical reactivity for the E1 subunit
of the V-ATPase (Figure 5a, c, and d). CAIII was detected
only in PT cells and not in other cell types, including the
a-type IC (Figure 5c and d, arrowheads). In ClC-5-deficient
kidney, the total number of CAIII-positive PT cells in the
outer cortex was increased approximately fourfold (17.1 vs
4.2% of Clcn5Y/þ PT cells) (Figure 5b). In addition,
immunoreactive signal for CAIII was detected in PT
of the inner cortex. The number of PT cells undergoing
apoptosis established by the TUNEL (terminal uridine
deoxynucleotidyl transferase dUTP nick end labeling)
reaction was similar in Clcn5Y/þ and Clcn5Y/ kidneys (data
not shown).
Immunogold analyses showed that in normal kidney
cortex, CAIII distribution was mainly cytosolic, also
including the apical brush border microvilli (Figure 6a and
d). Nuclei were labeled (Figure 6c and f), and a possible
endosomal labeling could not be excluded (Figure 6a and d).
No significant signal was noticed in mitochondria. In Clcn5Y/
samples, CAIII labeling appeared stronger than in Clcn5Y/þ
kidneys, with a similar distribution (Figure 6a–c vs d–f). The
predominant cytosolic distribution of CAIII, with residual
distribution in membrane and nuclear fractions, was
confirmed by subcellular fractionation of mouse kidneys, as
reported previously in hepatocytes (data not shown).14 Thus,
CAIII is essentially distributed in the cytosol of a subset of PT
cells in the outer cortex of normal mouse kidney. The loss of
ClC-5 causes a significant increase of CAIII expression in PT
cells of both outer and inner cortices, with a similar
subcellular localization.
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Figure 2 | Cell proliferation and oxidative stress in ClC-5-deficient kidney: immunostaining and hydroethidine fluorescence.
Immunostaining for proliferation markers, PCNA and Ki67, and measurement of superoxide anion generation in Clcn5Y/þ and Clcn5Y/ kidneys.
Counting of PCNA- and Ki67-positive cells along PT (p) indicates a B3-fold increase of proliferating PT cells in Clcn5Y/ vs Clcn5Y/þ kidneys
(n¼ 4 pairs). Values are presented as means±s.d.; *Po0.05. The detection of red fluorescent ethidium bromide shows a positive signal in
Clcn5Y/ PT (p), in strong contrast to Clcn5Y/þ samples (n¼ 3 pairs). Bars¼ 100 mm (insets, 50 mm).
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Upregulation of CAIII in human Dent’s disease kidney
samples
We investigated CAIII expression in two kidney cortex
samples from the end-stage kidney of a patient with Dent’s
disease owing to the G506E mutation of CLCN5.3 CAIII was
upregulated at both mRNA and protein levels in these
samples vs four end-stage kidney samples taken as controls
(Figure 7a and c). Real-time RT-PCR studies also showed an
induction of PCNA and thioredoxin expression in Dent
kidney samples (Figure 7b). Despite tissue damage due to
end-stage renal disease, the expression of CAIII could be
located in PT cells, identified by co-staining with aquaporin-
1 (Figure 7d). CAII was also apparently upregulated in Dent
kidney samples, potentially related to metabolic acidosis.
The CAII induction was not observed in mice lacking
ClC-5 (Figure 3), which have no renal failure.7 Although
restricted to a single human kidney, these results correlate
with the detection of CAIII in the urine of three other
patients with Dent’s disease and normal renal function
(Figure 4b). They support the hypothesis that the loss of
ClC-5 in the kidney is associated with proliferation,
protection against oxidative damage, and induction of CAIII
in PT cells.
Expression of CAIII mRNA in distinct mouse models of PT
dysfunction
To clarify whether CAIII induction was specifically caused by
ClC-5 inactivation or participated in a common cellular
response to PT dysfunction, CAIII mRNA expression was
investigated in two additional mouse models of renal Fanconi
syndrome, namely, the megalin- and cystinosin-deficient
mice. These models can be distinguished from each other by
the severity of PT defects.10,15 The expression of CAIII mRNA
was significantly increased in the kidneys of mice lacking
megalin (262±22% of WT level, n¼ 3), whereas no
changes were observed in the Ctns KO samples. Moreover,
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Figure 3 | Expression of CAIII in Clcn5Y/ vs Clcn5Y/þ kidneys. (a) Real-time RT-PCR quantification of mRNA expression of type III and II CA
isozymes in Clcn5Y/ vs Clcn5Y/þ kidneys (n¼ 6 pairs). The mRNA levels were adjusted to GAPDH and then compared between Clcn5Y/ and
Clcn5Y/þ samples, using the formula: ratio¼ 2DDCt :37 In normal mouse kidneys, CAIII mRNA expression representsB20% of CAII. By contrast,
in Clcn5Y/ samples, CAIII expression is B5 times increased, with no changes in CAII level. (b) Real-time RT-PCR quantification of CAIII mRNA
expression in Clcn5Y/ vs Clcn5Y/þ kidneys, epididymal fat, liver, skeletal muscle (vastus lateralis), lung, and male genital tract (n¼ 6 pairs). After
adjustment of mRNA levels to the reporter gene GAPDH, CAIII mRNA quantification was compared between Clcn5Y/ and Clcn5Y/þ samples,
using the formula: ratio¼ 2DDCt . The induction of CAIII caused by ClC-5 deficiency mostly involves kidneys, with a trend in epididymal fat and
no significant changes in other organs. (c) Characterization of anti-CAIII antibodies. A portion of 20 mg of cytosolic proteins from total Car3þ /þ
and Car3/ kidneys (n¼ 2 pairs of mice) was separated by SDS-PAGE and blotted onto nitrocellulose membrane, before incubation with
anti-CAII (1/2000) or anti-CAIII (1/1000) affinity-purified antibodies. The anti-CAIII antibodies do not detect any signal in the Car3/ kidneys,
whereas type II CA is detected with anti-CAII antibodies in both Car3þ /þ and Car3/ samples. Loading control was performed after
membrane stripping and incubation with monoclonal antibodies anti-b-actin (1/10 000). (d) Differential electrophoretic mobility of type II and
III CA isozymes. A portion of 20 mg of cytosolic proteins from total kidneys (n¼ 2 wild-type mice) was separated by SDS-PAGE and blotted onto
nitrocellulose membrane. Anti-CAII antibodies (1/2000) detected a unique band around B29 kDa, whereas CAIII was identified by anti-CAIII
antibodies (1/1000) at a slightly lower molecular weight (B27 kDa), without crossreactivity. (e, f) Representative immunoblotting for CAII and
CAIII in Clcn5Y/þ and Clcn5Y/ kidneys. A portion of 20 mg of cytosolic proteins was loaded in each lane. Blots were probed as in (c), and after
stripping for b-actin (1/10 000). Densitometry analyses show that CAIII expression is B4-fold higher in Clcn5Y/ kidneys than in controls
(385±43% of Clcn5Y/þ , n¼ 4 pairs of mice), whereas CAII abundance is unchanged (*Po0.05).
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immunoblotting analyses detected a specific excretion of
CAIII in the urine of mice lacking megalin (Figure 4c).
Induction of CAIII expression in PT cells exposed to H2O2
The HK-2 cell line is a well-established model for normal
human PT cells.16 Exposure of HK-2 cells to H2O2 1 mM
induced a significant increase in CAIII mRNA expression as
early as 3 h postincubation, with a maximal level observed at
6 h. Immunoblotting analyses showed an early and stable
induction of CAIII from 6 h postincubation with H2O2
(Figure 8). Similarly, exposure of OK cells to H2O2 0.3 mM
was associated with an increased expression of CAIII from 6 h
postincubation (data not shown). These data demonstrate
that PT cells rapidly increase their endogenous expression of
CAIII in response to oxidative conditions.
DISCUSSION
We show here that the functional loss of ClC-5, taken as a
paradigm of inherited PT dysfunction in mouse and man, is
associated with higher cell turnover and increased cellular
response to oxidant damage, as well as a major upregulation
of CAIII, a CA isoform with no established role in the kidney.
Studies in cultured PT cells suggest that the induction of
CAIII may be part of a cellular response to oxidative damage.
Owing to their intense reabsorptive activity involving
active transport processes, the epithelial cells lining the PT are
particularly vulnerable to injury. However, in contrast to the
brain and heart, the PT cells can recover from an ischemic or
toxic insult. After cell death by necrosis and apoptosis, the
surviving cells dedifferentiate and proliferate to eventually
replace the injured cells and restore tubular integrity.17 Our
studies reveal that a similar process occurs as a response to a
chronic injury, that is, inherited renal Fanconi syndrome in
mouse and man. The proliferative activity of PT cells,
assessed by using antibodies to cell proliferation-associated
nuclear proteins PCNA and KI-67, was almost fourfold
increased, with the involvement of the G1 cell cycle kinase
being suggested by the upregulated cyclin E. Furthermore, PT
cells underwent dedifferentiation, as indicated by the
expression of osteopontin and the mesodermal marker CAIII
(see below). These modifications occurred at a time when no
visible alterations in PT cell morphology or renal failure were
observed in ClC-5 KO mice,7 and neither was there any
change in the apoptotic rate.
The increased production of superoxide anion and the
induction of type I superoxide dismutase and thioredoxin
point to increased oxidative stress and solicitation of cell
oxidative defenses in ClC-5 KO kidneys. Thioredoxin was
also increased in a human kidney lacking functional ClC-5.
Oxidative stress has also been documented in PT lesions
induced by nephrotoxic compounds, such as cisplatin and
heavy metals,18,19 as well as in PT cells derived from patients
with a renal Fanconi syndrome due to cystinosis.11 These
disorders have in common an alteration of the receptor-
mediated endocytic uptake of albumin and LMW proteins,
and the possibility of a link between oxidative stress and
defective endocytosis could be raised. The endocytic defect
caused by the loss of ClC-5 is reflected in vivo by a selective
depletion of megalin (and its partner cubilin) from the brush
border in the absence of morphological lesion.6,8 Recently,
Guggino et al.20 suggested that megalin could act as a sensor
of albumin and that a decrease in its plasma membrane
expression could reduce protein kinase B activity and alter
the survival pathway involving phosphorylation of Bad in
cultured PT cells. The generalized trafficking defect in PT
cells lacking ClC-58 could also impair the translocation/
activation of protein kinase B, further reducing defense
against cytotoxicity. Furthermore, albumin is known to exert
a potent survival activity in mouse PT cells, most likely
through scavenging of reactive oxygen species,21 so that a
reduced capacity of albumin uptake may be deleterious. In
contrast, excessive albumin endocytosis also promotes H2O2
generation in PT cells.22 Thus, the link between oxidative
stress and defective endocytosis remains speculative, and the
two events could independently reflect the multiple changes
induced by the loss of ClC-5 in PT cells.
At least 15 different CA isoforms with 11 catalytically
active isozymes have been described in mammals, with
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Figure 4 | Urinary excretion of CAIII. (a) Urine samples from
Clcn5Y/þ and Clcn5Y/ mice (n¼ 4 pairs of mice) were loaded on
14% PAGE, blotted onto nitrocellulose, and incubated with anti-CAIII
antibodies (1/1000). Loading volume was normalized for urine
creatinine concentration. CAIII is exclusively detected in
Clcn5Y/ mouse urine. (b) Urine samples from three patients with
Dent’s disease and their carrier mothers were loaded on 14% PAGE,
blotted onto nitrocellulose, and incubated with anti-DBP (1/1000)
and anti-CAIII antibodies (1/1000). The LMW protein, DBP, is barely
detected in carriers and excreted in large amounts in patients. CAIII is
only detected in patients with Dent’s disease. Loading volume was
normalized for urine creatinine concentration. (c) Urine samples from
Lrp2þ /þ and Lrp2/ (megalin) mice (n¼ 3 pairs of mice) were
loaded, according to creatinine concentration, on 14% PAGE, blotted
onto nitrocellulose, and incubated with anti-CAIII antibodies (1/1000).
CAIII is specifically detected in megalin-deficient mouse urine.
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distinct kinetic properties and tissue distribution.12,23,24 The
cytosolic type II and membrane-bound type IV represent the
two major CA isoforms in the kidney, located in PT cells,
where they participate in Hþ secretion, HCO3
 reabsorption,
and NaCl homeostasis. CAII is also present in the intercalated
cells of the collecting duct, where it ensures net urinary
acidification. Two other CA isozymes (CAXIII and CAXIV)
have been located in the mouse kidney, but their specific role
remains unknown.12 The cytosolic CAIII isoform is charac-
terized by its resistance to sulfonamide inhibitors and its very
low CO2 hydration ability (B2% of CAII activity) due to
specific residues in the active site.24,25 CAIII is abundantly
expressed in the cytosol of skeletal muscle cells, adipocytes,
and hepatocytes.26 Trace amounts of CAIII have been
previously identified by radioimmunoassay in the rat
kidney,27 but no role for this isoform has ever been
mentioned.12
CAIII is known to function in an oxidizing environment,28
which is relevant when considering the oxidative stress
evidenced in mouse and human PT cells. Two reactive
sulfhydryl groups of CAIII are rapidly S-thiolated by
glutathione, after exposure to oxidative conditions, and
dethiolated by glutaredoxin- and thioredoxin-like reac-
tions.29 CAIII may also play a protective role against H2O2-
induced apoptosis, as NIH/3T3 cells overexpressing CAIII
grow faster and are more resistant to cytotoxic concentrations
of H2O2 than control cells.
30 It has been suggested that CAIII
functions as percarbonic acid anhydrase, which would
mediate H2O2þCO2 H2CO4 detoxification.26 The possi-
bility that CAIII may function as an oxyradical scavenger in
PT cells exposed to oxidative stress is supported by our
studies in HK-2 and OK cells exposed to H2O2. Further
studies should take advantage of the Car3 KO mice26 to verify
whether this role can be established in vivo.
What could be the mechanism of CAIII induction in PT
cells? Androgens regulate CAIII expression in the liver,31 but
we did not observe gender-dependent changes in CAIII
mRNA expression in the kidney (data not shown).
Thyroidectomy is known to increase CAIII concentration in
rat muscle,32 which could be relevant, as ClC-5 is involved in
thyroid endocytosis.33 However, ClC-5 KO mice develop a
euthyroid goiter, without alterations in circulating T4 and
thyroid-stimulating hormone levels.33 Specific transcription
factors may also regulate the transcription of CAIII in PT
cells. For instance, in silico analyses revealed several potential
hepatocyte nuclear factor 1 (HNF1) binding sites in the
promoter of the Car3 gene, and mice lacking HNF1a are
characterized by a decreased renal expression of CAIII
(F Jouret et al., unpublished observations).
The selective detection of CAIII in urine samples of
mice and patients lacking ClC-5 and other models of
PT dysfunction suggests that it may represent a useful
biomarker of renal Fanconi syndrome. As compared with
traditional markers, such as LMW proteins (for example,
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Figure 5 | Segmental distribution of CAIII in mouse kidney. Immunostaining for CAIII (a–c), V-ATPase E1 subunit (d) in Clcn5Y/þ (a, c–e),
and Clcn5Y/ (b). (c, d) are serial sections (p, proximal tubule). In mouse control kidney, CAIII is present in some tubules in the outer cortex (a).
In Clcn5Y/ kidney, CAIII distribution includes both outer and inner cortices, with a B4-fold increased number of CAIII-positive cells (b).
At higher magnification, CAIII is located in a subset of PT cells (c), identified by co-staining for the V-ATPase (d). The a-type intercalated cells
of the collecting duct, which apically express the V-ATPase, are strictly negative for CAIII (c, d, arrowheads). No signal is detected after
incubation with non-immune rabbit IgG (e). Bars¼ 100mm (a, b); 50 mm (c–e).
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b2-microglobulin), which are produced outside the kidney,
filtered but not reabsorbed owing to defective PT endocytosis,
or PT cell components (such as N-acetyl-b-glucosaminidase)
that appear in the urine in case of structural alterations,
CAIII in the urine may directly reflect a state of cellular
dysfunction, without changes in renal function or morpho-
logy. Furthermore, the upregulation of CAIII is organ- and
segment-specific, and it is clearly conserved in mouse and
man. Considering that CAIII is an early mesodermal
marker,34 it may reflect cell dedifferentiation along with
other genes encoding growth and transcription factors that
recapitulate the expression pattern seen during nephro-
genesis.17 Further investigations are necessary to substantiate
the role of CAIII in other types of inherited or acquired PT
dysfunction.
MATERIALS AND METHODS
Mouse models
Experiments were conducted on mice invalidated for Clcn5;7 Lrp2
(megalin);10 Ctns;15 or Car3.26 Mice lacking megalin in the kidney
exhibit defective PT endocytosis, resulting in osteopathy and
metabolic defects,10 whereas the Ctns KO mice present no signs of
proximal tubulopathy despite severe PT defects in infantile
cystinosis.15 The mice were housed in metabolic cages overnight
with ad libitum access to food and drinking water. Urine was
collected in ice-cold Complete protease inhibitors (Roche,
Vilvoorde, Belgium), total volume was measured, and the samples
immediately frozen and kept at 80 1C. An aliquot was used to
measure the levels of creatinine by standard methods (Eastman
Kodak Company, Rochester, NY, USA). All studies were in
accordance with the National Institutes of Health (NIH) guidelines
for the care and use of laboratory animals and approved by the
Committee for Animal Rights of the UCL.
Human samples
Two samples (outer cortex) from one end-stage kidney were
obtained at the time of nephrectomy in a patient with Dent’s
disease due to the G506E mutation in CLCN5.3 Four cortical
samples from end-stage kidneys (chronic interstitial nephritis)
removed during renal transplantation were used as controls. The
kidney samples were frozen in liquid nitrogen or fixed in 4%
formaldehyde. We obtained urine samples (second morning
miction) from three unrelated patients with Dent’s disease
harboring nonsense mutations (S203X, R637X, and R648X) in
CLCN5 and from their asymptomatic carrier mothers. All patients
(aged 7, 15, and 13 years, respectively) had LMW proteinuria and
hypercalciuria but no renal failure. The use of these samples has
been approved by the Ethical Review Board of the UCL.
PT cell lines
The human kidney (HK-2) and opossum kidney (OK) cell lines
were cultured as described.16 After 24 h serum deprivation,
subcultures of HK-2 (passage 12) and OK cells (passage 111) were
treated with H2O2 (1 or 0.3 mM, respectively) for 1–14 h. Cell pellets
were harvested and kept at –80 1C before mRNA and protein
extraction.
RNA extraction and double-strand cDNA synthesis
Total RNA was extracted using Trizol (Invitrogen, Merelbeke,
Belgium). For AFLP, poly(A)þ RNA was prepared from total
RNA using Dynabeads Oligo(dT)25 (Invitrogen). First-strand cDNA
was synthesized from 500 ng of poly(A)þ RNA using SuperScript II
RNase H Reverse Transcriptase (Invitrogen). Double-strand cDNA
was synthesized using T4 DNA Polymerase and purified using
QIAquick Extraction Kit (Qiagen, Venlo, The Netherlands).
AFLP reactions
The AFLP protocol was performed as described previously.35 cDNA
samples were digested with EcoRI and MseI (Fermentas, Vilnius,
Lithuania) and ligated to EcoRI and MseI double-strand adapters
(Supplementary Table S1) for 2 h at 20 1C. The restriction fragments
with ligated adapters were diluted (10 ) with TE buffer (100 mM
Tris-HCl, 10 mM EDTA, pH 8.0) and used as a template for the
pre-amplification reaction, which was performed for 20 cycles
(94 1C, 30 s; 56 1C, 1 min; 72 1C, 1 min) using Eco-P0 and Mse-P0
primers. The product was diluted (10 ) with TE buffer, and 5 ml
was used for selective amplification as follows: 33 cycles including 9
touchdown cycles comprising a decrease of the annealing tempera-
ture from 65 to 56 1C, which was maintained for 24 cycles. Twelve
primer combinations were used for selective amplification (Eco-PAA
and Mse-PAA or Mse-PAC or Mse-PAT; Eco-PAC and Mse-PAA or
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Figure 6 | Subcellular distribution of CAIII in Clcn5Y/þ and
Clcn5Y/ kidneys. EM immunocytochemistry for CAIII on ultrathin
cryosections from renal cortex of Clcn5Y/þ (a–c) and Clcn5Y/ mice
(d–f). Labeling appears stronger in the Clcn5Y/ samples than in
controls. The labeling is mainly cytosolic, extending to the apical
brush border (BB) microvilli (a, d). Nuclei (N) are also labeled (c, f), and
a possible endosomal labeling (E in a, d) cannot be excluded. The
very low signal in mitochondria (M) was considered to be
background. W and S in (b) denote weakly and strongly labeled
neighbor cells (compared with Figure 5). Bars¼ 0.5mm.
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Mse-PAC or Mse-PAT; Eco-PAG and Mse-PAA or Mse-PAC or
Mse-PAT; Eco-PAT and Mse-PAA or Mse-PAC or Mse-PAT) using an
iCycler Thermal Cycler (Bio-Rad, Nazareth, Belgium). The ampli-
fication products were denatured and separated on sequencing gels
(6% polyacrylamide, 6 M urea) that were then dried and exposed to
Kodak BioMax film (Amersham Biosciences, Buckinghamshire,
UK). The bands of interest were removed from the gel and recovered
by PCR. Reamplified cDNAs were visualized on a 1.5% (w/v)
agarose gel, subcloned into pGEM-T easy vector (Promega, Leiden,
The Netherlands), and sequenced (Genome Express, Meylan,
France). Each re-amplified AFLP fragment was analyzed using the
BLAST sequence alignment program (http://www.ncbi.nlm.nih.gov/
BLAST/).
Real-time RT-PCR
Total RNA was treated with DNase I (Invitrogen) and reverse-
transcribed using SuperScript III RNase H Reverse Transcriptase
(Invitrogen). Changes in mRNA expression levels were determined
by real-time RT-PCR (iCycler iQ System; Bio-Rad) using SYBR
Green I (Invitrogen).36 Specific primers were designed using Beacon
Primer Designer 2.0 (Premier Biosoft International, Palo Alto, CA,
USA) (Supplementary Table S2). The PCR products were sequenced
by Genome Express. The efficiency of each set of primers was
determined by dilution curves (Supplementary Table S2), and the Ct
differences between the reference (GAPDH, glyceraldehyde-3-
phosphate dehydrogenase) and target genes were calculated for
each sample of each genotype. The formula used to quantify the
relative changes in target over GAPDH mRNAs between the two
groups is derived from the 2DDCt formula as described by Pfaffl.37
Antibodies
The following antibodies were used: monoclonal antibodies against
CAIII (Spectral, Toronto, ON, Canada); V-ATPase E1 subunit (a gift
of Dr S Gluck, University of California, San Francisco, CA, USA);
PCNA (Dako, Heverlee, Belgium); b-actin (Sigma, St Louis, MO,
USA); and Ki67 antigen (Dako); and polyclonal antibodies against
CAIII;13 aquaporin-1 (Chemicon, Temecula, CA, USA); CAII
(Serotec, Oxford, UK); and vitamin D-binding protein (DBP)
(Dako). The specificity of anti-CAIII antibodies has been docu-
mented against purified CAI and CAII13 and in reference tissue
samples, including Car3 KO kidneys26 (Figure 3c), red blood cell
ghosts, and epididymis (data not shown).
Protein extraction and Immunoblotting
Cytosolic proteins were extracted from kidney samples as
described.7,36 Cell lysates were obtained by solubilizing frozen
pellets in lysis buffer containing Complete Mini (Roche), followed
by sonication and centrifugation at 16 000 g for 1 min at 4 1C.
Protein concentrations were determined using bicinchoninic acid
protein assay (Pierce, Aalst, Belgium). Tissue and urine samples
were thawed on ice, normalized for protein or creatinine levels,
diluted in Laemmli buffer, separated on sodium dodecyl
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Figure 7 | Expression and distribution of CAIII in human Dent’s disease kidney. (a, b) Real-time RT-PCR quantification of mRNA
expression of type III and II CA isozymes (a), osteopontin, PCNA, catalase, and thioredoxin (b) in two cortical samples from one end-stage
kidney from a patient with Dent’s disease vs four cortical samples obtained in end-stage kidneys of patients with an unrelated
pathology (ESRD). The mRNA levels were adjusted to GAPDH and quantified using the formula: ratio¼ 2DDCt . The CAIII mRNA expression
is B4-fold higher in Dent’s disease samples vs ESRD controls, and associated with increased PCNA and thioredoxin mRNA levels. Note
that CAII mRNA is also increased in the kidney samples of the patient with Dent’s disease. (c) Representative immunoblotting for CAIII
and CAII isoforms in the human kidney samples described above in (a). The blots were probed with antibodies against CAIII (1/1000)
or CAII (1/2000), and after stripping, b-actin (1/10 000). A strong CAIII expression is observed in Dent’s disease kidney. (d) Immunostaining
for CAIII (left) and aquaporin-1 (right) in human Dent’s disease kidney. CAIII is located diffusely in some PT cells (p), identified by
staining for AQP1.
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sulfate-polyacrylamide gel electrophoresis (10 7 cm, 14% gels) in
reducing conditions, and blotted onto nitrocellulose as described.36
Densitometry analysis was performed with a Canon CanoScan
8000F using the NIH Image V1.60 software.
Immunostaining and immunogold labeling
Kidney samples were fixed in 4% formaldehyde in 0.1 M phosphate
buffer, pH 7.4, and embedded in paraffin. Immunostaining was
performed on 6 mm sections using avidin–biotin peroxidase
(Vectastain Elite; Vector Laboratories, Labconsult, Brussels,
Belgium) and aminoethylcarbazole.37 Controls without primary
antibody or with non-immune IgG (Vector Laboratories) were
negative. Counting of PCNA-, Ki67-, and CAIII-positive PT cells
was blindly performed on five different cortex areas in four pairs of
Clcn5Y/ vs Clcn5Y/þ kidneys. For immunogold labeling, kidneys
were fixed by retrograde perfusion with 2% formaldehyde in 0.1 M
sodium cacodylate buffer, pH 7.2, and 70–90 nm cryosections were
obtained with an FCS Reichert Ultracut S cryo-ultramicrotome as
described.38 Sections were incubated with rabbit anti-CAIII at 4 1C
overnight, followed by incubation for 1 h with 10 nM goat anti-rabbit
gold particles (BioCell, Cardiff, UK). The cryosections were
embedded in methylcellulose containing 0.3% uranyl acetate and
studied in a Philips CM100 electron microscope. Controls with
secondary antibody alone or with nonspecific rabbit serum were
negative.
Detection of superoxide anion (O2
K–) generation
The in situ production of O2
K– in kidney sections was assessed
using the hydroethidine fluorescence method and detection
of fluorescent ethidium bromide as described.39 Briefly,
kidney cryosections were incubated with 50 ml of 2 106 M
HB solution (Invitrogen) in water at 37 1C for 30 min in a
light-protected and humidified chamber. Red fluorescence
from hydroethidine-treated samples was measured during
5 ms using the software KS400 (Zeiss, Zaventem, Belgium)
through a Zeiss Axiovert S100 microscope equipped with an
Axiocam camera.
Statistics
Results are expressed as means±s.d. Comparisons between groups
were made by Student’s unpaired t-tests. The significance level was
set at Po0.05.
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